HealthTech 250:
A decision-grade shortlist of digital health ventures—built from evidence, not hype

Top Digital Health Startup Trends in 2026

The 2026 HealthTech 250 identifies high-momentum ventures using a transparent, signal-based methodology across funding, commercial partnerships, and evidence.

What you get in the HealthTech 250 (2026) Download

The HealthTech 250 is organized in five XLSX lists designed for quick shortlisting, benchmarking, and outreach planning

United States

Top early-stage digital health ventures headquartered in the US, including top-funded deals such as Function Health ($298M).

Download xlsx

Asia Pacific

Digital health innovators across Singapore, India, Japan, and Australia driving telehealth, diagnostics, and AI-powered care delivery.

Download xlsx

Europe

Leading early-stage startups from the UK, France, Germany, Nordics, and Southern Europe building the next generation of health infrastructure.

Download xlsx

Rest of the World

High-potential ventures from Israel, Africa, Latin America, and the Middle East addressing healthcare access and diagnostic gaps.

Download xlsx

Top Clusters

The 3 leading innovation clusters across the HealthTech 250, with key trends, representative ventures, and average funding data.

Download xlsx

Get Access To All Data

Contact us to access the full HealthTech 250 dataset and the complete HealthTech Alpha platform.

Contact Us

Want the full universe beyond the HT250? HealthTech Alpha lets you expand the shortlist into a complete market map.

Download the HealthTech 250 lists (2026)

Complete the form to access the lists aligned with your interest.

What the 2026 HealthTech 250 is Signalling

Three shifts stand out in this year’s selection.

Resilience is the new moat

The most credible ventures are showing durability across capital, commercial traction, and evidence—not just fundraising.

Evidence signals are back in focus

Clinical validation and real-world adoption are increasingly differentiators as buyers tighten procurement standards.

Infrastructure is quietly winning

Enablers—workflow, data, and distribution layers—are scaling alongside care delivery and condition-led solutions.

HealthTech 250 is the Shortlist. HealthTech Alpha is the Engine

The HealthTech 250 is designed for fast signal capture. HealthTech Alpha is what teams use when they need repeatable, board-ready intelligence at scale.

Expand Beyond 250

Build market maps from the full venture universe and filter by theme, geography, stage, and signal strength.

Validate faster

Compare ventures using evidence, partnerships, funding momentum, and competitive context.

Operationalize scouting

Export shortlists, track momentum, and create repeatable workflows for BD, strategy, and investment teams.
Request a Demo

FAQs

What exactly am I downloading?
A set of five XLSX lists: US, Europe, Asia-Pacific, Rest of World, and Top Clusters—each designed for rapid shortlisting and benchmarking.
What does “HealthTech 250” mean?
A curated selection of digital health ventures identified using a signal-based approach combining funding momentum, partnerships, and evidence.
What ventures are eligible?
The 2026 edition focuses on ventures incorporated in 2021 or later, with a strong emphasis on Series A and below.
How current is the data?
This release is a snapshot as of 1 Feb 2026. HealthTech Alpha enables ongoing refresh as signals change.
Is this investment advice?
No. The HealthTech 250 is an intelligence product for market understanding and benchmarking. It is not investment advice.
What’s the difference between the HT250 and HealthTech Alpha?
HT250 is a shortlist. HealthTech Alpha provides the full dataset + filters + workflow tools to scout, compare, and track ventures continuously.

Who Is It For?

Intended Audience
Investors, Corporate Strategy, Pharma BD, Health Systems, and Corporate Digital Health teams.
Primary Use Cases
Rapid shortlisting, benchmarking, and ongoing market tracking of early-stage digital health ventures.